BTIG Research lifts Health Catalyst Inc [HCAT] price estimate. Who else is bullish?

MU Stock

Health Catalyst Inc [NASDAQ: HCAT] traded at a low on 2025-07-03, posting a 0.00 loss after which it closed the day’ session at $4.06.

The results of the trading session contributed to over 299053 shares changing hands. Over the past one week, the price volatility of Health Catalyst Inc stands at 5.53% while the volatility over the past one month is 5.94%.

The market cap for HCAT stock reached $282.58 million, with 69.48 million shares outstanding and 66.23 million shares in the current float. Compared to the average trading volume of 593.15K shares, HCAT reached a trading volume of 299053 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Health Catalyst Inc [HCAT]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HCAT shares is $7.20 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HCAT stock is a recommendation set at 1.77. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

BTIG Research have made an estimate for Health Catalyst Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on June 17, 2025. The new note on the price target was released on April 09, 2025, representing the official price target for Health Catalyst Inc stock. Previously, the target price had yet another raise to $9, while KeyBanc Capital Markets analysts kept a Overweight rating on HCAT stock.

The Price to Book ratio for the last quarter was 0.75, with the Price to Cash per share for the same quarter was set at 4.91.

How has HCAT stock performed recently?

Health Catalyst Inc [HCAT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 8.41. With this latest performance, HCAT shares gained by 0.50% in over the last four-week period, additionally sinking by -42.08% over the last 6 months – not to mention a drop of -42.57% in the past year of trading.

Health Catalyst Inc [HCAT]: Deeper insight into the fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Health Catalyst Inc [HCAT] shares currently have an operating margin of -16.40% and a Gross Margin at 32.05%. Health Catalyst Inc’s Net Margin is presently recorded at -23.34%.

Return on Equity for this stock declined to -9.16%, with Return on Assets sitting at -9.16%.

Earnings analysis for Health Catalyst Inc [HCAT]

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for HCAT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Health Catalyst Inc go to 29.99%.

Insider trade positions for Health Catalyst Inc [HCAT]

There are presently around $81.54%, or 84.26% of HCAT stock, in the hands of institutional investors. The top three institutional holders of HCAT stocks are: BLACKROCK INC. with ownership of 5.43 million shares, which is approximately 9.1608%. VANGUARD GROUP INC, holding 4.53 million shares of the stock with an approximate value of $$28.93 million in HCAT stocks shares; and VANGUARD GROUP INC, currently with $$25.28 million in HCAT stock with ownership which is approximately 6.6709%.

The DBT News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.